A Study of LY2510924 and Durvalumab in Participants With Solid Tumors
Clinical trial NCT02737072 · TERMINATED
Trial details
- NCT number
- NCT02737072
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-09-25
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.